Emergent BioSolutions (EBS) Misses Q4 EPS by 35c; Offers FY23 Revenue Guidance
Go back to Emergent BioSolutions (EBS) Misses Q4 EPS by 35c; Offers FY23 Revenue Guidance| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 4.59 +0.10 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.49 | 52 Week High | $44.38 | |||
| Open | $4.50 | 52 Week Low | $24.47 | |||
| Day High | $4.67 | P/E | 229.50 | |||
| Day Low | $4.45 | EPS | $0.02 | |||
| Volume | 1,094,302 | |||||
